The beneficial effects of GLP-1 RAs on HRQoL and other outcomes in HFpEF are likely due to pleiotropic impacts, related or not to weight reduction, such as decongestion (mainly due to the reduction of increased plasma volume associated with obesity and epicardial constrain), reverse cardiac remodelling (mainly due to the decrease in epicardial fat and regression of left atrial and LV myopathy, lowering intracardiac pressure) and anti-inflammatory actions, among others
Photo by Innerbody Research Nearly two-thirds of Americans experience at least one gastrointestinal (GI) problem daily,1 and about eight million annual trips to the emergency room are related to GI concerns.2 Yet these problems often never receive a diagnosis, and even the lucky few with diagnoses dont often receive treatment that alleviates their symptoms
Weight management is often gradual, and small changes may become noticeable over time with consistent effort
A key component of BALANCE is lifestyle support you wont just get the GLP-1
Dihexa is sold as a research chemical, not a supplement or approved drug, and is not for human consumption
